LSV Asset Management Grows Position in Varex Imaging $VREX

LSV Asset Management boosted its holdings in Varex Imaging (NASDAQ:VREX) by 210.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,244,329 shares of the company’s stock after acquiring an additional 843,805 shares during the quarter. LSV Asset Management’s holdings in Varex Imaging were worth $14,496,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its position in shares of Varex Imaging by 381.8% in the third quarter. JPMorgan Chase & Co. now owns 284,227 shares of the company’s stock valued at $3,524,000 after buying an additional 225,238 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Varex Imaging in the fourth quarter valued at $1,247,000. SummerHaven Investment Management LLC purchased a new position in shares of Varex Imaging in the third quarter valued at $1,233,000. Assenagon Asset Management S.A. increased its position in shares of Varex Imaging by 79.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 532,748 shares of the company’s stock valued at $6,207,000 after buying an additional 236,620 shares in the last quarter. Finally, Fox Run Management L.L.C. purchased a new position in shares of Varex Imaging in the third quarter valued at $684,000.

Varex Imaging Price Performance

Shares of NASDAQ:VREX opened at $10.07 on Tuesday. The stock’s 50-day moving average price is $10.95 and its two-hundred day moving average price is $12.00. The company has a current ratio of 3.20, a quick ratio of 1.43 and a debt-to-equity ratio of 0.67. Varex Imaging has a 12-month low of $6.76 and a 12-month high of $14.56. The firm has a market cap of $423.95 million, a price-to-earnings ratio of -5.04 and a beta of 0.96.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.01). The firm had revenue of $216.00 million during the quarter, compared to analyst estimates of $216.92 million. Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.19%. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. On average, research analysts forecast that Varex Imaging will post 0.93 EPS for the current year.

Insiders Place Their Bets

In other Varex Imaging news, Director Jay K. Kunkel sold 4,510 shares of the company’s stock in a transaction that occurred on Friday, March 20th. The stock was sold at an average price of $11.14, for a total value of $50,241.40. Following the completion of the transaction, the director owned 23,450 shares in the company, valued at $261,233. This represents a 16.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 4.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on VREX shares. Jefferies Financial Group restated a “hold” rating and issued a $14.50 price target on shares of Varex Imaging in a research report on Monday, February 2nd. B. Riley Financial reaffirmed a “buy” rating on shares of Varex Imaging in a research note on Thursday, February 12th. Wall Street Zen lowered Varex Imaging from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Zacks Research raised Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a research note on Friday, March 27th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.17.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.